×

Our Best Shot - CHI’s Mandatory COVID-19 Vaccination Policy

To ensure maximum safety, CHI has instituted a mandatory COVID-19 vaccination policy for all in-person participants across all our events. We feel it is our community duty to ensure CHI events are part of the COVID-19 solution to reopening safely. We are confident the scientific community, which developed the vaccine, will rally behind us on this first-of-its-kind policy.

SAVE THE DATE for next year's Conference:  February 21-23, 2022

The 2021 Tri-Con Virtual Conference may be over now, but that doesn't mean you have to miss it.  Order it now On-Demand! 

Celebrating its 28th year, Molecular Medicine Tri-Conference drew more than 1,000 virtual participants!

Molecular Medicine Tri-Con 2021 Highlights
This year the Molecular Med Tri-Conference participants gathered virtually over 3 days to discuss the latest research and technologies in COVID-19 diagnostics, vaccines and biotherapeutics, point-of-care diagnostics, biomarkers and liquid biopsy, data analytics and artificial intelligence.

The 2021 program offered 8 distinct conferences, and four plenary keynote sessions, focused on advances and innovative solutions in all aspects of molecular & precision medicine, including COVID-19 Vaccines & Biotherapeutics, Circulating Tumor Cells and Liquid Biopsy, Immuno-Oncology Biomarkers, Point-of-Care Diagnostics, Clinical & Translational Biomarkers and Data, Analytics & AI for Precision Medicine.

The impressive audience at Molecular Medicine Tri-Conference had more than 50% of the attendees titled as a decision-maker from leading Pharma (17%), Biotech companies (50%), and Healthcare (11%). Industry leaders and key decision-makers representing 28 different countries and more than 450 unique organizations shared case studies, collaborated on best practices, and provided unique perspectives on poignant issues that the field currently faces.


Mark your calendar for 2022
29th Annual Molecular Medicine Tri-Conference 2022
February 21-23, 2022
(New Location) Hilton San Diego Bayfront / San Diego, California




2021 Featured Speakers

Timothy Stenzel
Director, Office of In Vitro Diagnostics and Radiological Health
FDA

Hanneke Schuitemaker
VP, Viral Vaccine Discovery & Translational Medicine
Janssen

Mene Pangalos
EVP, Biopharmaceuticals R&D
AstraZeneca

Cecilia Schott

Cecilia Schott
Head, Global Precision Medicine Strategy
Novartis

Sanjay Gurunathan
VP, Head, Clinical Sciences
Sanofi

Karen Kaul

Karen Kaul
Chair, Pathology and Laboratory Medicine
NorthShore University HealthSystem

Steven Schachter

Steven Schachter
RADx Chief; Professor
Harvard Medical School

Esther Babady

Esther Babady
Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center

Robert Johnson

Robert Johnson
Director, Infectious Disease
BARDA

Hakan Sakul
VP, Head, Diagnostics
Pfizer

Zhen Su
Merck KGaA Darmstadt, Germany

Razelle Kurzrock

Razelle Kurzrock
Director, Personalized Cancer Therapy
UCSD

Charles Chiu

Charles Chiu
Director, UCSF-Abbott Viral Diagnostics and Discovery Center
UCSF

Peter Hotez
Dean, National School of Tropical Medicine
Baylor College of Medicine

Carolyn Compton

Carolyn Compton
CMO
National Biomarker Development Alliance

Kristin Blouch

Kristin Blouch
Director, Disease Characterization
GlaxoSmithKline

Michael Snyder

Michael Snyder
Director, Genomics & Personalized Medicine
Stanford

Mark T. Esser

Mark T. Esser
VP, Microbial Sciences
AstraZeneca

Dan Barouch

Dan Barouch
Director, Virology and Vaccine Research
Beth Israel Deaconess Medical Center

Tomas Cihlar

Tomas Cihlar
VP, Virology
Gilead

Stay Connected Before February… Join us Now for the Free Webinar Series





TRICON Community News and Resources

POST EVENT ON-DEMAND NOW AVAILABLEOrder Now

FREE WEBINARS: Sponsor a Webinar or Register Free | View Details

PROGRAM UPDATE: Preliminary Program Just Released! | Join mailing list



Sponsorship and Exhibit Opportunities

Molecular Med Tri-Con provides an immense opportunity to reach over 3000 thought leaders working on COVID-19 diagnostics and vaccines, point-of-care diagnostics, biomarkers and liquid biopsy, data analytics and artificial intelligence, and immuno-oncology and cell therapy. Explore our sponsor and exhibitor packages offering a wide range of platforms to launch products, present within the main agenda, build brand awareness, network with attendees, and generate viable leads. 




Key Contacts

For partnering & sponsorship, please contact:
Jon Stroup
Sr. Business Development Manager
Cambridge Healthtech Institute
781-972-5483 jstroup@healthtech.com

For meeting questions or suggestions, please contact:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
juliab@healthtech.com

For media and association partnerships, please contact:
Jennifer Salhus
Sr. Marketing Manager
Cambridge Healthtech Institute
781.972.5492
jsalhus@healthtech.com